Articles on Dr. Ohhira's OMX:
>
Nutritional Protection Against Bioterrorism
>
Bacterial Count Discussion Regarding A Five - Year, Natural Temperature Fementation Japanese Probiotic Product
>
Antioxidant Property And Upper Gastrointestinal Tract Conditions As Affected By OM-X Probiotic Capsules
>
Inhibition Of Helicobacter Pylori
 

Inhibition Of Helicobacter Pylori

The 12 strains of lactic acid bacteria in the OMX capsule showed antimicrobial activity against H. pylori in vitro as shown by loss of viability of the latter.
A well diffusion assay technique was used. One OMX Capsule was dissolved and incubated in All purpose Medium with Tween (APT) broth with or without biotin for good recovery of the organisms from the capsule. The results obtained in Table 5 is the mean of duplicate tests. The colonies recovered from the capsule dissolved in water and then plated on APT agar and de Man, Rogosa and Sharpe (MRS) agar showed decrease in the number of colony forming units of the H.pylori strains (NCTC11637 & NCTC11638).
This preliminary results explains how viable lactic acid bacteria contained in live capsule based probiotic can bring about much relief to those suffering from peptic ulcers and gastritis by inhibiting the H.pylori infection.

GROWTH INHIBITION ON E. COLI 0157

The component from TH10 strain was extracted with ethyl acetate and then neutralised by regulating the Ph. Then variable rates (0.75, 1.5, 3.0, 6.0, 12 and 24 mg) of the lactic acid bacteria extract were introduced on dipped paper discs into petri dishes containing cultured viable colonies of E. coli 0157 in several replicates. These petti dishes were incubated at 37 degrees centigrade. Growth inhibitions of the 0157 strain were monitored by observing the diameter of zones of inhibitions obtained around the paper discs.

Results indicated that inhibition of 0157 were obtained at all amounts of 3.0mg and above of the extract. Consistent results were obtained on repetition. Inhibitory effects were increased with more amount of the extract.

The substance acting on the 0157 strain is initially made out to be of low molecular weight and further research is being carried out to specify its structure and mechanism of activity.

MODE OF ACTION

At this stage the explanation that can be offered is the action of the different bacteriocins and the lowering of pH by the OMX inhibiting the proliferation of the antagonistic microorganisms. With the five years fermentation and low pH achieved it is found that the acidolin produced by the Lactobacillus acidophilus is particularly active against bacteria and viruses. This evidence is further supported by earlier research of Hamdan and Mikolajcik (1974). This makes OMX lactic acid bacteria highly effective in terms of its antimicrobial property as well as a functional food supplement.

REFERENCES

Lilley, DM and Stillwell, R H (1965). Probiotics: growth promoting factors produced by microorganisms. Science 147 : 747 - 748

Parker, R B (1974). Probiotics, the other half of the antibiotic story. Anim. Nutr.
Health 29 : 4 - 8.

Fuller, R (1989). Probiotics in man and animals. J. Appl. Bacteriol. 66: 365 - 378.

Hamdan, I Y and Mikolajcik, E M (1974). Acidolin: an antibiotic produced by Lactobacillus acidophilus. Journal of Antibiotics 8 : 631 - 636.

TABLE 1: AMINO ACID CONTENTS IN OMX CAPSULE SAMPLE
AMINO ACIDS 11/100
Arginine 0.10
Lysine 0.10
Histidine 0.08
Phenylalanine 0.26
Tyrosine 0.14
Lcucine 0.41
Isoleucine 0.25
Methionine 0.05
Valine 0.28
Alanine 0.22
Glycine 0.19
Proline 0.42
Glutamic acid 1.11
Serine 0.22
Threonine 0.18
Aspartic acid 0.68
Tryptophan 0.04
Cystine 0.06

TABLE 2: Level of essential minerals in samples of ONIX capsules
Mineral Level (mg/ 100g)
Phosphorus 176
Iron 4.07
Calcium 123
Sodium 58.6
Potassium 899

TABLE 3: TO SHOW BIOSAFETY OF OMX CAPSULE CONTENTS
No.
Heavy metal
Level in OMX
Permitted level(Food Regulation Act 1985)
01.
Arscnic (As) 0.22
1
02.
Lead (Pb) 0.07
2
03.
Copper (Cu) 0.53
30
04.
Tin (Sn) 0.04
40
05.
Zinc (Zn) 3.33
40
06.
Mercury (Hg) Not detected
0.05
07.
Cadmium (Cd) Not detected
1
08.
Antimony (Sb) Not detected
1
09.
Total plate countof lactic acidbacteria per capsule 59,000,000 cfu
*parts per million (ppm), maximum

TABLE4 : INHIBITION OF ETHYL ACETATE EXTRACT OF
ENTEROCOCCUS FAECALIS TH10
Test organism
Dosage (mg)
20 10 5
Methicillin resistant Staphylococcus aureus
+
+
Enterococcus faecalis RIMD 3116001
-
-
Enterococcus faecium
-
-
Streptococciissalivarius
+
-
Pediococcus pentosaceus
-
-
Lactococcus lactis subsp. Lactis
-
-
Leuconostoc mesenteroides subsp. Mesenteroides
-
-
Lactobacillus plantarum
-
-
Lactobacillus delbrueckii
-
-
Dry weight of the ethyl acetate extract+ Growth inhibition of test organism around paper disk- No inhibition
-
-

TABLE5 : INHIBITION OF HELICOBACTER PYLORI STRAINS (NCTC 11637 & 11638) AFTER 24 HRS IN WCACB BROTH WITH PREDISSOLVED OMX CAPSULE FOR
18 HRS
SAMPLES
SAMPLES TIME
 
O hrs
24 hrs
 
7
9
H.pylori NCTC 11637
2 x 10 cfu / ml
9 x 10 cfu / ml
 
7
4
H.pylori NCTC 11637 + OMX capsule
2 x 10 cfu / ml
3 x 10 cfu / ml
 
7
9
H.pylori NCTC 11638
5 x 10 cfu / ml
8 x 10 cfu / ml
 
7
3
H.pylori NCTC 11638 + OMX capsule
5 x 10 cfu / ml
8 x 10 cfu / ml

^TOP

 
 

The above information is provided for general educational purposes only. It is not intended to replace competent health care advice received from a knowledgeable healthcare professional. You are urged to seek healthcare advice for the treatment of any illness or disease.

Copyright © bioeonline.com. All rights reserved.

 

Sole Agent for Singapore, Australia, Indonesia, Hong Kong & China